Single and multiple point NRAS mutations in acute myeloid leukemia: a study of 327 well molecularly characterized patients
- 1 September 2022
- journal article
- other
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 63 (13) , 3237-3240
Abstract
Oncogenic mutations in the NRAS gene are carried by 10–22% acute myeloid leukemia (AML) patients and represent one of the most commonly detected molecular aberrations in AML [1–6]. The mutations le...Keywords
Funding Information
- Ministry of Health of the Czech Republic (15-25809A)
- Ministry of Education, Youth and Sports of the Czech Republic (MUNI/A/1330/2021)
- Ministry of Health of the Czech Republic (FNBr, 65269705)
This publication has 14 references indexed in Scilit:
- Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemiaBlood, 2016
- Genomic Classification and Prognosis in Acute Myeloid LeukemiaNew England Journal of Medicine, 2016
- Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemiaAnnals of Hematology, 2014
- Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG)Blood, 2013
- Clinical and proteomic characterization of acute myeloid leukemia with mutated RASCancer, 2012
- RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosisBlood, 2011
- Hyperactive Ras in developmental disorders and cancerNature Reviews Cancer, 2007
- Implications of NRAS mutations in AML: a study of 2502 patientsBlood, 2006
- RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 yearsBlood, 2005
- Clonal Analysis of Multiple Point Mutations in the N‐ras Gene in Patients with Acute Myeloid LeukemiaJapanese Journal of Cancer Research, 1993